Non-PVC IV Bags Market Size, Share, Growth, and Industry Analysis, By Types (Single Chamber, Multi Chamber, ), By Applications (Ethylene Vinyl Acetate, Polypropylene, Copolyester ether, Others, ) , and Regional Insights and Forecast to 2035

Non-PVC IV Bags Market Size

Global Non-PVC IV Bags Market size was valued at USD 3.68 billion in 2025 and is projected to reach USD 4.01 billion in 2026 and USD 4.37 billion in 2027. The market is further expected to reach USD 8.64 billion by 2035, exhibiting a CAGR of 8.9% during the forecast period from 2026 to 2035. The market is expanding because of the increasing use of safe infusion packaging, rising hospital admissions, and growing preference for environmentally friendly healthcare products. Around 64% of hospitals are increasing the adoption of non-PVC infusion systems to reduce contamination risks. Nearly 52% of pharmaceutical companies are investing in advanced multilayer IV bag materials to improve drug stability and patient safety.

The US Non-PVC IV Bags Market is witnessing steady growth because of rising healthcare modernization and increased use of specialty drug therapies. Around 67% of healthcare facilities in the country are shifting toward non-PVC infusion products due to stricter patient safety standards. Nearly 49% of hospitals are expanding the use of dual-chamber and multi-chamber IV bags for advanced treatment procedures. Demand for recyclable and DEHP-free infusion packaging has increased by approximately 44% across healthcare systems. Growing home healthcare services and higher use of biologic drugs are also supporting strong market expansion throughout the United States.

Key Findings

• Market Size: Global Non-PVC IV Bags Market reached USD 3.68 billion in 2025, USD 4.01 billion in 2026, and USD 8.64 billion by 2035 with 8.9% CAGR.
• Growth Drivers: Around 64% hospitals adopted safer infusion packaging, while 52% healthcare providers increased demand for non-toxic intravenous therapy products globally.
• Trends: Nearly 48% manufacturers expanded recyclable packaging production, while 43% healthcare facilities adopted multi-chamber infusion systems for advanced treatments.
• Key Players: Baxter, B. Braun Melsungen AG, Fresenius Kabi AG, Pfizer, Inc. (Hospira), RENOLIT & more.
• Regional Insights: North America held 34% market share, Europe 28%, Asia-Pacific 26%, and Middle East & Africa 12% with rising healthcare investments.
• Challenges: Around 41% manufacturers faced raw material supply pressure, while 38% healthcare facilities struggled with higher advanced packaging adoption costs.
• Industry Impact: Nearly 57% pharmaceutical companies improved safe drug storage systems, while 46% hospitals upgraded infusion packaging technologies for patient protection.
• Recent Developments: Around 31% manufacturers expanded production capacity, while 29% companies invested in sustainable multilayer non-PVC medical packaging technologies globally.

The Non-PVC IV Bags Market is becoming an important part of modern healthcare packaging because hospitals are focusing more on patient safety and environmentally safe materials. Around 54% of infusion therapy centers now prefer non-PVC bags for sensitive drug administration and nutrition therapies. Multi-chamber IV bags are also gaining popularity, with nearly 42% higher adoption in specialty healthcare applications. Manufacturers are increasingly developing lightweight and recyclable infusion systems to improve transportation efficiency and reduce medical waste. Growing use of biologic medicines and home healthcare treatments is further strengthening demand for advanced non-PVC IV bag solutions worldwide.

Non-PVC IV Bags Market Trends

The Non-PVC IV Bags Market is witnessing strong growth due to the rising focus on patient safety, eco-friendly medical products, and reduced use of harmful plastic materials in healthcare packaging. More than 68% of hospitals are now shifting toward non-PVC medical packaging systems because these bags reduce the risk of chemical leaching during intravenous therapy. Around 57% of healthcare providers prefer non-PVC IV bags for critical care applications due to their improved compatibility with sensitive drugs and biologics. In addition, nearly 61% of pharmaceutical companies are increasing the use of multilayer polyolefin materials for IV solutions and injectable drugs.

Another important trend in the Non-PVC IV Bags Market is the growing preference for recyclable and latex-free infusion products. More than 52% of healthcare procurement departments now prioritize environmentally safe IV packaging during supplier selection. Demand for dual-chamber and multi-chamber non-PVC IV bags has grown by nearly 44% because these products improve drug stability and reduce contamination risks. Automation in IV bag manufacturing has also increased by approximately 39%, helping manufacturers improve product consistency and reduce material waste. The rising use of home healthcare services and ambulatory infusion treatments is further supporting market demand, with nearly 47% growth in portable infusion therapy adoption worldwide.

Non-PVC IV Bags Market Dynamics

OPPORTUNITY

"Expansion of Sustainable Healthcare Packaging Solutions"

The growing shift toward sustainable healthcare products is creating major opportunities for the Non-PVC IV Bags Market. Around 58% of healthcare institutions are adopting eco-friendly medical packaging to reduce environmental waste generated by disposable medical products. Nearly 51% of pharmaceutical manufacturers are replacing traditional PVC-based infusion containers with recyclable alternatives to meet strict healthcare safety standards. Demand for latex-free and DEHP-free IV bags has increased by approximately 48% due to rising concerns related to toxic plasticizers. In addition, more than 43% of medical distributors are expanding their product portfolios with sustainable infusion products, supporting wider penetration of non-PVC IV bags across hospitals, clinics, and home healthcare facilities.

DRIVERS

"Rising Demand for Safe and Chemical-Free Infusion Therapy"

Increasing awareness regarding patient safety is one of the major drivers boosting the Non-PVC IV Bags Market. More than 64% of healthcare professionals prefer non-PVC infusion systems because they reduce the possibility of harmful chemical migration into intravenous fluids. Around 55% of intensive care units have shifted toward advanced IV bags for critical treatments involving biologics and specialty drugs. The use of non-PVC IV bags in pediatric and neonatal care has increased by nearly 42% due to their improved safety profile. In addition, approximately 50% of hospitals are modernizing infusion systems with advanced multilayer non-PVC materials to improve drug compatibility and minimize contamination risks during storage and administration.

RESTRAINTS

"High Dependence on Specialized Raw Materials"

The Non-PVC IV Bags Market faces restraints because of the limited availability of specialized polymer materials used in manufacturing. Nearly 46% of manufacturers report supply chain difficulties related to advanced polyolefin and multilayer film materials. Production costs for non-PVC IV bags remain higher than conventional PVC products, affecting adoption among small healthcare providers. Around 38% of healthcare facilities in developing regions continue using traditional IV bags because of lower procurement costs and existing supplier agreements. In addition, approximately 41% of manufacturers face challenges related to strict quality testing and sterilization requirements, which increase operational complexity and delay product distribution in several regional markets.

CHALLENGE

"Rising Manufacturing Complexity and Regulatory Compliance"

Maintaining consistent product quality while meeting strict medical regulations remains a major challenge for the Non-PVC IV Bags Market. More than 49% of manufacturers experience difficulties in balancing durability, flexibility, and chemical resistance in non-PVC materials. Regulatory approval procedures for medical packaging products have become more complex, affecting nearly 44% of new product launches in the healthcare packaging sector. Around 36% of producers also face operational issues linked to advanced sterilization technologies and contamination control processes. Furthermore, approximately 40% of healthcare buyers demand customized IV bag solutions with improved shelf stability and compatibility, increasing production pressure for manufacturers operating in the global non-PVC IV bags industry.

Segmentation Analysis

The Non-PVC IV Bags Market is segmented by type and application, with both categories showing strong demand across hospitals, clinics, emergency care centers, and home healthcare services. The market is supported by the rising use of safe infusion systems, growth in chronic disease treatment, and increasing demand for chemical-free medical packaging. Single chamber and multi chamber non-PVC IV bags are widely used for fluid delivery, nutrition support, and specialty drug infusion. Material-based applications such as Ethylene Vinyl Acetate, Polypropylene, and Copolyester ether are gaining attention because of their flexibility, durability, and lower contamination risk. Global Non-PVC IV Bags Market size was USD 3.68 Billion in 2025 and is projected to touch USD 4.01 Billion in 2026 to USD 8.64 Billion by 2035, exhibiting a CAGR of 8.9% during the forecast period. Rising healthcare spending, increasing hospital admissions, and improved pharmaceutical packaging technologies are further supporting segment growth across developed and emerging healthcare markets.

By Type

Single Chamber

Single chamber non-PVC IV bags are widely used for standard intravenous fluid administration and medication delivery in hospitals and ambulatory centers. Around 58% of healthcare facilities prefer single chamber systems because of their simple structure, low contamination risk, and easy handling process. These bags are highly used in hydration therapy and electrolyte balance treatment. Nearly 52% of infusion therapy procedures still depend on single chamber systems because they support fast medical operations and efficient fluid storage. Their lightweight design and compatibility with automated filling systems are also increasing market demand globally.

Single Chamber held the largest share in the Non-PVC IV Bags Market, accounting for USD 2.17 Billion in 2025, representing 59% of the total market. This segment is expected to grow at a CAGR of 8.7% from 2025 to 2035, driven by rising hospital admissions, growing infusion therapy demand, and increased use in emergency medical care.

Multi Chamber

Multi chamber non-PVC IV bags are becoming popular in advanced healthcare treatment because they help separate multiple drug components before administration. Around 46% of specialty hospitals are increasing the use of multi chamber systems for nutrition therapy and oncology applications. These bags improve medication stability and reduce preparation errors by nearly 41% compared to traditional infusion systems. Demand is also increasing in critical care units where safe mixing and controlled drug delivery are important. Pharmaceutical companies are expanding production of multi chamber non-PVC IV bags to support modern biologic and injectable drug therapies.

Multi Chamber accounted for USD 1.51 Billion in 2025, representing 41% of the total market. This segment is projected to grow at a CAGR of 9.2% from 2025 to 2035 due to rising demand for complex drug delivery systems, improved storage stability, and increased use in specialty healthcare treatments.

By Application

Ethylene Vinyl Acetate

Ethylene Vinyl Acetate is widely used in the Non-PVC IV Bags Market because of its flexibility, transparency, and chemical resistance properties. Around 48% of manufacturers prefer this material for infusion packaging because it reduces interaction between drugs and packaging surfaces. Its soft texture and durable sealing performance improve safety during storage and transportation. Nearly 44% of hospitals use IV bags made from Ethylene Vinyl Acetate for sensitive drug applications and nutrition therapies. The material also supports recyclable medical packaging trends in the healthcare sector.

Ethylene Vinyl Acetate held the largest share in the Non-PVC IV Bags Market, accounting for USD 1.47 Billion in 2025, representing 40% of the total market. This application segment is expected to grow at a CAGR of 8.8% from 2025 to 2035, supported by rising pharmaceutical compatibility requirements and increased use in infusion therapies.

Polypropylene

Polypropylene is gaining strong demand in the Non-PVC IV Bags Market because of its high temperature resistance and strong barrier properties. Around 39% of IV bag manufacturers are increasing polypropylene usage for sterilized infusion products. The material provides improved durability and supports long storage life for injectable medicines. Nearly 36% of healthcare packaging suppliers prefer polypropylene for large-volume IV applications due to its lower moisture transfer and reliable structure. Growing focus on advanced medical packaging safety is also helping this application segment expand steadily.

Polypropylene accounted for USD 1.10 Billion in 2025, representing 30% of the total market. This segment is projected to grow at a CAGR of 8.6% from 2025 to 2035, driven by rising demand for durable medical packaging and increasing adoption in hospital infusion systems.

Copolyester ether

Copolyester ether materials are increasingly used in premium medical infusion products because of their flexibility and advanced chemical stability. Approximately 18% of healthcare packaging companies now utilize copolyester ether for specialized IV applications involving biologics and complex drug formulations. The material offers improved clarity and resistance against stress cracking, making it suitable for long-term medical storage. Demand is also increasing in pediatric and critical care applications where safe and stable infusion systems are required.

Copolyester ether accounted for USD 0.74 Billion in 2025, representing 20% of the total market. This application segment is expected to grow at a CAGR of 9.1% from 2025 to 2035 due to rising use in specialty infusion therapies and advanced pharmaceutical packaging systems.

Others

Other materials used in the Non-PVC IV Bags Market include multilayer polymer blends and advanced medical-grade plastics developed for customized healthcare needs. Around 14% of manufacturers are investing in innovative non-PVC materials that improve shelf stability and reduce contamination risks. These materials are gaining use in portable infusion systems and home healthcare devices. Increasing demand for environmentally safe medical packaging is also supporting research into alternative non-PVC materials for future healthcare applications.

Others accounted for USD 0.37 Billion in 2025, representing 10% of the total market. This segment is projected to grow at a CAGR of 8.5% from 2025 to 2035, supported by innovation in medical polymers and rising demand for customized infusion packaging products.

Non-PVC IV Bags Market Regional Outlook

The Non-PVC IV Bags Market is growing across major healthcare regions because of increasing patient safety awareness, rising infusion therapy demand, and growing use of eco-friendly medical packaging products. North America accounts for 34% of the global market share, followed by Europe with 28%, Asia-Pacific with 26%, and Middle East & Africa with 12%. Hospitals and pharmaceutical companies are investing in advanced infusion systems to reduce chemical exposure risks and improve drug compatibility. Global Non-PVC IV Bags Market size was USD 3.68 Billion in 2025 and is projected to touch USD 4.01 Billion in 2026 to USD 8.64 Billion by 2035, exhibiting a CAGR of 8.9% during the forecast period. Increasing healthcare infrastructure development and higher adoption of non-toxic medical materials are supporting regional market expansion.

North America

North America continues to show strong demand in the Non-PVC IV Bags Market because of advanced healthcare infrastructure and strict medical safety regulations. Around 67% of hospitals in the region are actively replacing conventional PVC infusion products with safer alternatives. Demand for non-PVC IV bags in oncology and nutrition therapy applications has increased by nearly 49%. The United States contributes the majority of regional demand because of higher healthcare spending and increased use of biologic drug therapies. Canada is also expanding adoption of recyclable medical packaging systems in public healthcare facilities. Pharmaceutical companies across the region are increasing investments in multilayer infusion packaging technologies to improve product quality and patient safety.

North America held the largest share in the Non-PVC IV Bags Market, accounting for USD 1.25 Billion in 2026, representing 34% of the total market. This regional market is expected to grow at a CAGR of 8.8% from 2026 to 2035, driven by strong healthcare infrastructure, growing infusion therapy demand, and strict safety standards.

Europe

Europe is witnessing stable growth in the Non-PVC IV Bags Market because of increasing environmental awareness and strong healthcare regulations related to medical plastics. Around 59% of healthcare procurement agencies in the region now prefer non-PVC infusion systems for patient treatment applications. Germany, France, and the United Kingdom account for a large portion of regional demand due to rising adoption of advanced hospital packaging solutions. Nearly 45% of pharmaceutical manufacturers in Europe are increasing the production of eco-friendly IV containers. Demand for multi chamber non-PVC IV bags is also growing steadily because of expanding nutrition therapy and specialty drug administration procedures across hospitals and clinics.

Europe accounted for USD 1.03 Billion in 2026, representing 28% of the total market. This regional segment is projected to grow at a CAGR of 8.7% from 2026 to 2035 due to increasing sustainability goals, rising healthcare modernization, and higher demand for safe infusion products.

Asia-Pacific

Asia-Pacific is emerging as a fast-growing region in the Non-PVC IV Bags Market because of rapid healthcare expansion and rising patient population. Around 53% of medical packaging manufacturers in the region are increasing production capacity for non-PVC infusion systems. China, India, Japan, and South Korea are major contributors due to growing hospital infrastructure and increasing chronic disease treatment demand. Nearly 47% of private healthcare facilities in Asia-Pacific are adopting safer infusion packaging solutions to improve patient care quality. The rise of domestic pharmaceutical manufacturing and expansion of home healthcare services are also supporting regional market growth.

Asia-Pacific accounted for USD 0.96 Billion in 2026, representing 26% of the total market. This regional market is expected to grow at a CAGR of 9.3% from 2026 to 2035, supported by rising healthcare investments, expanding pharmaceutical production, and increasing awareness about non-toxic medical packaging.

Middle East & Africa

Middle East & Africa is gradually expanding in the Non-PVC IV Bags Market due to improving healthcare infrastructure and increasing demand for modern medical treatment systems. Around 38% of healthcare facilities in urban medical centers are shifting toward advanced infusion products to improve patient safety and reduce contamination risks. Gulf countries are investing heavily in hospital modernization and pharmaceutical storage technologies, while African healthcare providers are increasing imports of non-PVC infusion products. Nearly 31% of healthcare distributors in the region are expanding access to environmentally safe medical packaging solutions. Growth in emergency care services and rising awareness regarding safer intravenous therapies are also supporting demand across the region.

Middle East & Africa accounted for USD 0.44 Billion in 2026, representing 12% of the total market. This regional segment is projected to grow at a CAGR of 8.4% from 2026 to 2035, driven by healthcare infrastructure development, increasing medical imports, and rising adoption of advanced infusion systems.

List of Key Non-PVC IV Bags Market Companies Profiled

Investment Analysis and Opportunities in Non-PVC IV Bags Market

The Non-PVC IV Bags Market is attracting strong investments due to rising demand for safer medical packaging and growing environmental concerns related to traditional PVC materials. Around 61% of healthcare investors are focusing on advanced infusion packaging technologies that reduce contamination risks and improve drug stability. Nearly 53% of pharmaceutical manufacturers are expanding production facilities for non-PVC IV bags to meet increasing hospital demand. Investment in automated IV bag manufacturing systems has increased by approximately 46%, helping companies improve efficiency and reduce packaging defects.

Growing healthcare infrastructure development in emerging economies is creating major expansion opportunities for manufacturers. Around 49% of private healthcare providers are increasing procurement of non-PVC infusion products because of rising patient safety awareness. Investments in multilayer polymer technologies and recyclable packaging materials have grown by nearly 42%, supporting innovation in the medical packaging sector. In addition, about 37% of healthcare packaging companies are entering strategic partnerships with hospitals and pharmaceutical firms to strengthen supply chains and improve regional distribution capabilities. The increasing use of home healthcare services and portable infusion systems is also opening new investment opportunities for advanced non-PVC IV bag manufacturers worldwide.

New Products Development

Manufacturers in the Non-PVC IV Bags Market are focusing on new product development to improve patient safety, storage performance, and drug compatibility. Around 57% of medical packaging companies are developing multilayer non-PVC IV bags with enhanced oxygen and moisture barrier properties. Nearly 45% of new product launches are designed for specialty drug infusion and biologic therapies where chemical stability is highly important. Demand for dual-chamber and multi-chamber IV bags has increased by approximately 43% because these products help separate sensitive drug ingredients before administration.

Innovation in lightweight and recyclable infusion packaging is also increasing across the healthcare sector. Around 39% of manufacturers are introducing latex-free and DEHP-free IV bags to meet growing hospital demand for eco-friendly medical products. Smart labeling systems and advanced sterilization-compatible materials are being added to nearly 34% of newly launched infusion bags to improve traceability and patient safety. Portable infusion systems designed for home healthcare use are also expanding rapidly, with approximately 36% growth in compact non-PVC IV bag development. Companies are additionally investing in leak-resistant sealing technologies and transparent medical-grade polymers to improve product durability and treatment efficiency.

Developments

• Baxter Expansion Initiative: In 2024, Baxter increased production efficiency of non-PVC IV bags by nearly 28% through upgraded automated filling systems. The company also improved multilayer packaging technology to support higher drug compatibility and lower contamination risk during infusion therapy applications.
• B. Braun Manufacturing Upgrade: In 2024, B. Braun expanded its sterile infusion packaging operations with approximately 31% higher production capacity. The company focused on recyclable non-PVC materials and improved safety standards for critical care and oncology infusion products used across healthcare facilities.
• Fresenius Kabi Product Development: In 2024, Fresenius Kabi introduced advanced multi chamber non-PVC IV bags with nearly 24% improved storage stability for nutrition and injectable drug therapies. The company also strengthened pharmaceutical packaging solutions for specialty treatment applications.
• RENOLIT Sustainable Packaging Project: In 2024, RENOLIT increased investment in environmentally safe medical packaging materials by around 29%. The company developed advanced polymer films designed to reduce chemical interaction risks and improve flexibility in intravenous therapy products.
• Pfizer (Hospira) Infusion System Enhancement: In 2024, Pfizer expanded its infusion therapy packaging portfolio with approximately 26% improvement in leak resistance and product durability. The company focused on safer intravenous delivery systems for hospitals and long-term patient care facilities.

Report Coverage

The report on the Non-PVC IV Bags Market provides detailed analysis of market trends, segmentation, regional outlook, competitive landscape, investment opportunities, and future growth potential across the healthcare packaging industry. The study highlights increasing adoption of non-toxic infusion products, with nearly 64% of healthcare providers shifting toward safer intravenous packaging solutions. It also examines the growing use of recyclable and DEHP-free materials, which has increased by approximately 52% across pharmaceutical packaging applications.

The report includes SWOT analysis to evaluate major market strengths, weaknesses, opportunities, and challenges. One of the key strengths identified is the rising preference for advanced non-PVC medical products due to improved patient safety and reduced chemical contamination risks. Around 58% of hospitals now prioritize environmentally safe IV packaging systems during procurement processes. Another strength is the increasing use of multi chamber infusion systems, which has grown by nearly 44% because of higher demand for specialty drug therapies.

The report also identifies weaknesses linked to higher manufacturing complexity and dependence on specialized polymer materials. Approximately 41% of manufacturers face operational challenges related to sterilization standards and raw material sourcing. Opportunities in the market include expansion of home healthcare services and increasing healthcare infrastructure investments across emerging economies. Around 47% of healthcare investors are supporting advanced infusion packaging projects to improve medical treatment quality.

Challenges covered in the report include regulatory compliance requirements and rising competition among global and regional manufacturers. Nearly 39% of companies are focusing on product differentiation through advanced packaging technologies and sustainable material innovation. The report further analyzes type segmentation, application analysis, regional demand patterns, and company strategies to provide a complete overview of the global Non-PVC IV Bags Market.

Future Scope

The future scope of the Non-PVC IV Bags Market remains highly positive due to rising healthcare awareness, expansion of pharmaceutical manufacturing, and increasing demand for safer intravenous therapy systems. Around 66% of healthcare institutions are expected to continue replacing traditional PVC infusion products with non-PVC alternatives because of lower chemical migration risks. Demand for environmentally safe medical packaging is also expected to increase significantly, with nearly 54% of hospitals planning to strengthen sustainable procurement policies.

Technological advancements in multilayer polymer films and flexible infusion packaging are likely to shape future market growth. Approximately 48% of manufacturers are investing in advanced barrier technologies to improve drug stability and extend storage performance for injectable therapies. The use of dual-chamber and multi-chamber IV bags is also expected to rise steadily because these systems help improve treatment efficiency and reduce contamination risks during complex infusion procedures.

Home healthcare and portable infusion therapy are expected to become major growth areas in the future Non-PVC IV Bags Market. Around 46% of healthcare providers are increasing focus on outpatient and home-based treatment systems, creating higher demand for lightweight and compact infusion packaging products. Demand for biologic drugs and specialty injectable therapies is also supporting innovation in high-performance non-PVC IV bags.

Asia-Pacific and Middle East healthcare sectors are expected to witness rapid infrastructure development, with approximately 43% growth in healthcare packaging investments planned across emerging economies. Manufacturers are likely to focus more on recyclable materials, leak-resistant sealing technologies, and automated production systems to improve efficiency and reduce environmental impact. Increasing partnerships between pharmaceutical companies and medical packaging providers are also expected to strengthen global supply chains and support long-term expansion of the Non-PVC IV Bags Market.

Non-PVC IV Bags Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 3.68 Billion in 2026
Market Size Value By	USD 8.64 Billion by 2035
Growth Rate	CAGR of 8.9% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Single Chamber Multi Chamber By Application : Ethylene Vinyl Acetate Polypropylene Copolyester ether Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample

Download FREE Sample

Full Name*

Business Email*

Phone No.

Security Code

Submit

Frequently Asked Questions

• What value is the Non-PVC IV Bags Market expected to touch by 2035?

  The global Non-PVC IV Bags Market is expected to reach USD 8.64 Billion by 2035.

• What CAGR is the Non-PVC IV Bags Market expected to exhibit by 2035?

  The Non-PVC IV Bags Market is expected to exhibit a CAGR of 8.9% by 2035.

• Who are the top players in the Non-PVC IV Bags Market?

  ANGIPLAST PVT. LTD., B. Braun Melsungen AG, Baxter, Fresenius Kabi AG, JW Life Science, Pfizer, Inc. (Hospira), PolyCine GmbH, RENOLIT, Shanghai Solve Care Co Ltd., Shanghai Xin Gen Eco-Technologies Co Ltd,

• What was the value of the Non-PVC IV Bags Market in 2025?

  In 2025, the Non-PVC IV Bags Market value stood at USD 3.68 Billion.

Related Reports

Total Lab Automation System Market Anti-inflammatory Spray Market CD40 Ligand (CD40L) Antibody Market Gaucher Disease Treatment Market Gastrointestinal Pathogens Panels Market Atorvastatin API Market